So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can't rely on them ...

The global hunt for an HIV cure remains a puzzle, despite nearly 40 years of research and progress in treatment and prevention. Scientists have struggled largely because of the virus's ability ...

Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were ...

Global Fund notes that the US has contributed more than $26.31 billion to date and pledged up to $6 billion for the Seventh ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

In early 2025, the US decision to halt foreign aid for HIV/AIDS programs triggered global concerns about a potential ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

You can notice signs of HIV on the tongue during the early and late stages of the infection with the virus. An acute HIV ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

More treatment facilities have been established in Eastern Visayas in response to the rising number of human immunodeficiency ...

Franke says that at the time he heard about the "Berlin patient" Timothy Brown, who was also freed of HIV after a stem cell ...